NCCN Guidelines
Breast Cancer
Guidelines
-
NCCN Guidelines Version 4.2021
- Breast Cancer During Pregnancy
- Ductal Carcinoma in situ
- Inflammatory Breast Cancer
- Invasive Breast Cancer
- Paget Disease
- Phyllodes Tumor
Frameworks
-
Basic Resources (English) Version 3.2020 (Preliminary)
-
Core Resources (English) Version 3.2020 (Preliminary)
-
Enhanced Resources (English) Version 3.2020 (Preliminary)
Guidelines for Patients
-
Invasive Breast Cancer-English Version 2020
-
Metastatic Breast Cancer-English Version 2020
-
DCIS Breast Cancer-English Version 2020
-
Invasive Breast Cancer-Russian Version 2018
-
Metastatic Breast Cancer-Russian Version 2018
-
DCIS Breast Cancer-Russian Version 2018
-
Metastatic Breast Cancer-French Canadian Version 2018
-
Invasive Breast Cancer-French Canadian Version 2018
-
DCIS Breast Cancer-French Canadian Version 2018
Educational Events and Programs
Continuing Education
-
Recorded Presentation from the NCCN Pharmacy Updates: New Targets in Breast Cancer Therapy
-
HER2-Positive Breast Cancer: A Guide Through An Evolving Treatment Landscape
-
Understanding/Addressing Health Disparities to Improve Breast Cancer Care
-
Genetic Testing in Patients with Breast Cancer: Who Should Get Tested?
-
Surgical and Radiation Treatment Updates to Management of Breast Cancer, Including SABCS Updates
-
Adjuvant and Neoadjuvant Therapies for Breast Cancer, Including SABCS Updates
-
Breast Cancer in Young Adults: Treatment Considerations and Supportive Care Options
-
Updates to the Systemic Treatment of Metastatic Breast Cancer, Including SABCS Updates
International
Translations
-
Chinese Version 4.2021
-
French Version 6.2020
-
Japanese Version 5.2020
-
Korean Version 6.2020
-
Polish Version 6.2020
-
Portuguese Version 6.2020
-
Spanish Version 4.2021
Adaptations
-
English (Middle East & North Africa) Version 2.2016
-
Spanish (European) Version 3.2019
Harmonized
-
English (Caribbean) Version 1.2018
-
English (Africa) Version 1.2019